Tooth loss strongly linked to risk of esophageal, head and neck, and lung cancer

Studying thousands of patients, Japanese researchers have found a strong link between tooth loss and increased risk of three cancers – esophageal, head and neck, and lung. They suggest that preservation of teeth may decrease risk of developing these diseases.

In the May issue of Cancer Epidemiology, Biomarkers and Prevention, a journal of the American Association for Cancer Research, scientists from Aichi Cancer Center in Nagoya and Nagoya University Graduate School of Medicine speculate that bacterial infection and inflammation resulting from poor oral care that leads to tooth loss could also be driving development of these cancers. Periodontal disease is known to increase risk for stroke and heart disease.

“Tooth loss is a common consequence of chronic bacterial infection and may, therefore, serve as a surrogate for chronic infection and inflammation, which in turn may be important to the pathogenesis of cancer,” said the study’s lead author, Akio Hiraki, Ph.D., a researcher at the Aichi Cancer Center.

Researchers measured rates of 14 different cancers and rates of tooth loss in 5,240 cancer patients in Japan, and compared those rates among 10,480 matched cancer-free participants. The researchers specifically found that people with tooth loss were 136 percent more likely to develop esophageal cancer, had a 68 percent increased risk of developing head and neck cancer and a 54 percent greater chance of developing lung cancer. The researchers also found that the rate of cancer increased proportionally to the number of teeth a patient had lost.

These increased risks were seen after researchers took into account a patient’s history of smoking and alcohol use.

Smaller studies have linked tooth loss to different cancers, but this is the largest study to date, and the first conducted within an Asian population, the researchers say. This is also the first study to show a link to lung cancer, they add.

The researchers noted that age and gender affected the associations between tooth loss and cancer risk. For head and neck and esophageal cancers, there were clear associations between tooth loss and cancer risk in women and patients younger than 70 years old, but a less clear link in men and older patients.

The researchers say that while widespread inflammation could explain the link between tooth loss and cancer risk, they also note that tooth loss in the cancer patients may simply reflect unhealthy behaviors that contribute to cancer risk. Furthermore, people who have lost teeth may not be able to eat a healthy diet, and diet is also a factor in cancer development.

Whatever the mechanism, the researchers stress that oral care is critical to good health.

“The oral cavity is a gateway between the external environment and the gastrointestinal tract and acts in both food ingestion and digestion,” the researchers wrote. “Oral hygiene potentially affects gastrointestinal flora and nutritional status and may thus have implications for the development of chronic disease.”

Source: American Association for Cancer Research

Related stories:

Oral osteoporosis meds appear to reduce the risk of jaw degradation
BOSTON, Mass. (Jan. 2, 2008) — Athanasios Zavras began receiving messages from distraught patients in 2005 after case reports linked oral osteoporosis meds to bone death in the jaw. A number of doctors and dentists advised women and men taking these drugs to postpone dental work, fearing that procedures such as tooth extractions would exacerbate the problem. That’s when Zavras, an associate professor in the Harvard School of Dental Medicine, decided to take a closer look at the purported link.
Nanomaterials Key to New Strategies for Blocking Metastasis
A new treatment strategy using targeted nanoparticles to block metastasis with anti-cancer drugs leads to good results using significantly lower doses of toxic chemotherapy, with less collateral damage to surrounding tissue, according to a collaborative team of researchers at the Center of Nanotechnology for Treatment, Understanding, and Monitoring of Cancer at the University of California, San Diego. In designing this system, the investigators, led by David Cheresh, Ph.D., have identified what may become a generic method for using nanotechnology to target metastasis.
New study ties ending moderate drinking to depression
Scientific evidence has long suggested that moderate drinking offers some protection against heart disease, certain types of stroke and some forms of cancer.
'Smart bomb' nanoparticle strategy impacts metastasis
A new treatment strategy using molecular "smart bombs" to target metastasis with anti-cancer drugs leads to good results using significantly lower doses of toxic chemotherapy, with less collateral damage to surrounding tissue, according to a collaborative team of researchers at the University of California, San Diego.
Bacterial peptide provides new insight into common tumor suppressor
Scientists have identified a new antitumor drug that might prove useful in developing treatments for a multiple human cancers. The research, published by Cell Press in the July 8 issue of the journal Cancer Cell, advances the understanding of one of the most frequently disrupted tumor suppressor proteins in human cancer and provides new insight into the regulation of the complex process of cellular protein degradation under normal and pathological conditions.
Researchers find molecule that kills kidney cancer cells
Kidney cancer patients generally have one option for beating their disease: surgery to remove the organ.
Looking for the Founatain of Youth? Cut your calories, research suggests
Want to slow the signs of aging and live longer? New Saint Louis University research suggests cutting back on calories could be a promising strategy.
Blood vessel inhibitor shows promise against metastatic thyroid cancer
Thyroid cancer that has spread to distant sites has a poor prognosis, but an experimental drug that inhibits tumor blood vessel formation can slow disease progression in some patients, a research team led by investigators from The University of Texas M. D. Anderson Cancer Center reports in the July 3rd edition of The New England Journal of Medicine.

News discussion:

Medicine & Health news